Invention Grant
US09109218B2 Human arginase and pegylated human arginase and the use thereof
有权
人精氨酸酶和聚乙二醇化人精氨酸酶及其用途
- Patent Title: Human arginase and pegylated human arginase and the use thereof
- Patent Title (中): 人精氨酸酶和聚乙二醇化人精氨酸酶及其用途
-
Application No.: US14368507Application Date: 2012-12-23
-
Publication No.: US09109218B2Publication Date: 2015-08-18
- Inventor: Ning Man Cheng , Li Chen
- Applicant: BIO-CANCER TREATMENT INTERNATIONAL LTD. (SHANGHAI)
- Applicant Address: CN Shanghai
- Assignee: Bio-Cancer Treatment International Ltd. (Shanghai)
- Current Assignee: Bio-Cancer Treatment International Ltd. (Shanghai)
- Current Assignee Address: CN Shanghai
- Agency: Eagle IP Limited
- Agent Jacqueline C. Lui
- Priority: CN201110445965 20111227; CN201210069626 20120316
- International Application: PCT/CN2012/087241 WO 20121223
- International Announcement: WO2013/097658 WO 20130704
- Main IPC: C12N9/78
- IPC: C12N9/78 ; A61K38/50 ; C12N9/96
Abstract:
The present invention provides a site-directed mutated arginase and the preparation method thereof, and the use of said site-directed mutated arginase in preparing a medicament for treating an arginase-related disease. The present invention also provides a pegylated arginase and the preparation method thereof, and the use of said pegylated arginase in preparing a medicament for treating an arginase-related disease.
Public/Granted literature
- US20140363417A1 Human Arginase and Pegylated Human Arginase and the UseThereof Public/Granted day:2014-12-11
Information query
